Q

Qiagen NV
D

QGEN

39.570
USD
1.01
(2.62%)
مغلق
حجم التداول
67,426
الربح لكل سهم
2
العائد الربحي
-
P/E
86
حجم السوق
8,551,681,511
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    A
    A
    -1.400
    (-1.02%)
    135.400 USD
    BDX
    BDX
    -0.590
    (-0.26%)
    227.450 USD
    B
    BIO
    -6.57
    (-2.29%)
    279.85 USD
    D
    DGX
    0.115
    (0.07%)
    172.290 USD
    H
    HOLX
    0.180
    (0.28%)
    64.510 USD
    IDXX
    IDXX
    -0.33
    (-0.07%)
    452.66 USD
    ILMN
    ILMN
    -3.080
    (-3.17%)
    94.180 USD
    L
    LH
    0.655
    (0.26%)
    249.865 USD
    TMO
    TMO
    -5.71
    (-1.06%)
    532.28 USD
    المزيد
الأخبار
المقالات

العنوان: Qiagen N.V.

القطاع: Healthcare
الصناعة: Diagnostics & Research
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).